Page 1

HEADLINES -=6

 Indian Market

DAILY EQUITY NEWSLETTER 17TH MAY 2013

Indian equity markets were up 0.38%

Nifty up by 23.15 pts and settle at 6169.90

Sensex up by 34.37 pts at 20247.33

Bank Nifty up by 161.60 pts at 13239.50

 Global Market 

European markets were up with FTSE up by 8.99 closed at 6702 ,CAC down by 10.34 closed at 3971 and DAX down 9.82 closed at 8352 Dow future was up by 1 closed at 15236.00

 HEADLINES • AirAsia's Chandilya will have to be cost leader in India • RBI to kickstart sale of inflation-indexed bonds on June 4 • Adani Ports Q4 net profit triples to Rs 710.31 cr • CARE's Q4 revenue at Rs 63 crore, net at Rs 36 crore

WWW.EPICRESEARCH.CO

09752199966


 MARKET ANALYSIS:  Key benchmark indices nudged higher as index heavyweight Reliance Industries (RIL) gained. The barometer index, the S&P BSE Sensex, was provisionally up 34.31 points or 0.7%, off close to 80 points from the day's high and up about 85 points from the day's low. The market breadth, indicating the overall health of the market, was negative.  Index heavyweight and cigarette major ITC dropped ahead of its Q4 results tomorrow, 17 May 2013. Auto stocks fell. Bajaj Auto declined on reporting weak Q4 results. Pharma stocks rose on renewed buying, with Lupin hitting record high and Glenmark Pharmaceuticals hitting 52-week high. Reliance Capital turned volatile after reporting weak Q4 results.  Indian stocks gained for the third straight day today, 16 May 2013.Foreign institutional investors (FIIs) bought shares worth a net Rs 1646.95 crore on Wednesday, 15 May 2013, as per provisional data from the stock exchanges.  As per provisional figures, the S&P BSE Sensex was up 34.31 points or 0.7% to 20,247.27. The index rose 113.52 points at the day's high of 20,326.48 in morning trade, its highest level since 6 January 2011. The index fell 50.84 points at the day's low of 20,162.12 in opening trade. Pharma stocks rose on renewed buying. Cipla, Dr Reddy's Laboratories, and Ranbaxy Laboratories rose by 2.3% to 3.04%. Sun Pharmaceutical Industries fell 0.39%.Lupin rose 3.08% to Rs 806.60. The stock hit record high of Rs 810.80 in intraday trade today, 16 May 2013.

 FII’s and DII’s

STOCKS TO WATCH BAJAJ AUTO

CATEGORY

DATE

BUY

SELL

NET

CAIRN INDIA

FII

15-May-13

4362.4

2715.45

1646.95

TCS

DII

15-May-13

1244.05

1991.16

-747.11

INFOSYS

SCRIPS IN BAN PERIOD

 NIFTY DAILY PIVOTS PIVOT

R4

R3

R2

R1

PP

S1

S2

S3

S4

NIFTY

6338

6279

6220

6194

6161

6135

6102

6043

5984

WWW.EPICRESEARCH.CO

09752199966


.

 GAINERS AND LOOSERS

EXPERT OPINION NIFTY

DAILY NIFTY GAINERS SCRIPS

JP Associate

RATE

80.05

VOL.

PR.

NET

%

(000)

CLOSE

CHAN

CHANG

GE

E

32873.81

75.80

4.25

5.61

Nifty looks Bearish

Strategy: Sell on rise

Support: 6100

Resistance: 6200 BANK NIFTY

IDFC

163.35

9529.19

158.05

5.30

3.35

Lupin

806.90

1775.87

782.00

24.90

3.18

Cipla

422.10

2601.21

411.10

11.00

2.68

Reliance Indus

840.65

3473.90

819.00

21.65

2.64

Bank Nifty looks Bearish

Strategy: Sell on rise

Support: 13000

Resistance: 13150 460

.0 PREVIOUS PERFORMANCE TYPE

SCRIP

B/S

RESULT

CASH

RELIANCE COMMUNICATION

B

TGT HIT

CASH

VOLTAS

B

TGT HIT

FUTURE

APOLLO TYRE

B

TGT HIT

FUTURE

ADANI POWER

S

NOT EXECUTED

DAILY NIFTY LOOSERS SCRIPS

NMDC Tata Motors

RATE

124.55

VOL.

PR.

NET

%

(000)

CLOSE

CHAN

CHAN

GE

GE

2382.96

128.35

-3.80

-2.96

303.65

5186.19

308.85

-5.20

-1.68

ITC

337.00

7384.78

342.45

-5.45

-1.59

Jindal Steel & Power

308.35

2629.50

312.70

-4.35

-1.39

TCS

1454.05

1207.83

1471.55

-17.50

-1.19

WWW.EPICRESEARCH.CO

09752199966


MARKET CALLS CASH

6 SCRIPS

ACTION

LEVEL

1ST TARGET

2ND TARGET

STOP LOSS

ALLAHBAD BANK

BUY

127.00

128.00

129.00

126.00

SESA GOA

BUY

168.50

169.50

170.50

167.50

FUTURE SCRIPS

ACTION

LEVEL

ST

1

TARGET

ND

2

TARGET

STOP LOSS

. APOLLO TYRE

BUY

92.60

93.10

93.60

92.10

CROMPTON GREAVES

BUY

97.40

97.90

98.40

96.90

Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.

daily equity 17 may 2013  

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex...

Read more
Read more
Similar to
Popular now
Just for you